Orphan Designated Drugs
Q4 2023 update: orphan designated drugs related private equity activity in the pharmaceutical industry
Certa plans pivotal scleroderma trial after Phase II data readout
Q3 2023 update: orphan designated drugs related private equity activity in the pharmaceutical industry
Q3 2023 update: orphan designated drugs related M&A activity in the pharmaceutical industry
How did the pharmaceutical industry treat orphan designated drugs in Q3 2023 filings?
How did the pharmaceutical industry treat orphan designated drugs in Q4 2023 filings?
